Explore >> Select a destination

You are here

 www.cardiobrief.org
Novel Drug Delivers Long Term Cholesterol Reduction
| | blog.philbirnbaum.com
Sabermetric Research: The NEJM hydroxychloroquine study fails to notice its largest effect
3.8 parsecs away

Travel
| |
| | www.detroitnews.com
Novo's Ozempic slashes risk of death in kidney disease study
2.3 parsecs away

Travel
| | Novo Nordisk A/S's blockbuster diabetes drug Ozempic cut patients' risk of dying in a kidney-disease study, the latest research pointing to the medicine's usefulness in a constellation of disorders.
| | www.cureffi.org
FDA approval of the first RNAi drug
3.8 parsecs away

Travel
| | 20 years after the discovery of RNA interference, the first drug is approved. Great news, but our path forward for prion disease remains unchanged.
| | www.health.harvard.edu
A placebo can work even when you know it's a placebo - Harvard Health
24.7 parsecs away

Travel
| You may have heard of the "placebo effect," in which people taking an inactive drug as part of a study actually experience an improvement in their symptoms. As it turns out, the placebo effect still exists if you tell people they're taking a placebo. This "open-label placebo" strategy doesn'...